OpenVSafe by OpenVAERS
Search V-safe

9R9-77219-60778

2 vaccinations 5 coded responses 7 check-ins 5 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
950 / CA
Registered
2021-03-05
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-05
    Registered in v-safe
  2. 2021-03-05
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-05
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Nausea
    Adult check-in
  4. 2021-03-06
    Survey response — days 1–6 daily, dose 1
    MedDRA: Gastrooesophageal reflux disease, Injection site pain, Nausea, Oropharyngeal pain — Feeling: Good
    Free text: 1. Feeling of sore throat, possibly caused by acid reflux (had some nausea before acid reflux). 2. Mild soreness at injection site.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-02
    Dose 2 — Pfizer-BioNTech
  7. 2021-04-02
    Survey response — day 0, dose 2
    MedDRA: Decreased appetite, Dysgeusia, Nasal congestion — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: loss of appetite, nasal congestion, bitter taste on tongue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Decreased appetite, Dysgeusia, Dyspepsia, Eructation, Injection site pain — Feeling: Fair · Fatigue or tiredness, Nausea
    Free text: soreness at injection site (mild to moderate), limited appetite, heartburn, some belching, bitter taste on tongue (last 3 symptoms most likely connected to acid reflux).
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-04
    Survey response — days 1–6 daily, dose 2
    MedDRA: Decreased appetite — Feeling: Fair · Nausea
    Free text: somewhat limited appetite
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-05
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dyspepsia, Oropharyngeal pain — Feeling: Good · Nausea
    Free text: heartburn (mild), sore throat feeling (may be from acid reflux)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-05Pfizer-BioNTech
22021-04-02Pfizer-BioNTech

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-06

Systemic reaction (other): 1. Feeling of sore throat, possibly caused by acid reflux (had some nausea before acid reflux). 2. Mild soreness at injection site.

Release 6 — day 0, dose 2

2021-04-02

Systemic reaction (other): loss of appetite, nasal congestion, bitter taste on tongue

Release 6 — days 1–6 daily, dose 2

2021-04-03

Systemic reaction (other): soreness at injection site (mild to moderate), limited appetite, heartburn, some belching, bitter taste on tongue (last 3 symptoms most likely connected to acid reflux).

2021-04-04

Systemic reaction (other): somewhat limited appetite

2021-04-05

Systemic reaction (other): heartburn (mild), sore throat feeling (may be from acid reflux)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SRODecreased appetite ✓ ✓ ✓
SRODysgeusia ✓ ✓ ✓
SRODyspepsia ✓ ✓ ✓
SROEructation ✓ ✓ ✓
SROGastrooesophageal reflux disease ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SRONasal congestion ✓ ✓ ✓
SRONausea ✓ ✓ ✓
SROOropharyngeal pain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release